Loading...

AMRX AMNEAL PHARMACEUTICALS INC Capital Structure Changes 8-K Filing

MNL

MRX

AMNEAL PHARMACEUTICALS INC

(AMRX)

2025 8-K

Q3 Earnings Report

Financial Statements

Debt Restructuring

Debt Restructuring

Debt-Equity Swaps

Appointing directors

Financial Statements

Earnings Announcement

2024 Financial Guidance

Earnings Update

Q3 Earnings Report

Strategic Collaboration

Earnings Reports

Annual Meeting of Stockholders

Reaffirmation of Guidance

Product Launch/Discontinuation

Amendment and New Credit Ag...

Reorganization Plan

Financial Results Announcement

Quantitative Data

Settlement Agreement

Annual Meeting Results

Financial Results Announcement

Reaffirmation of Financial ...

External Links:

On July 24, 2025, Amneal Pharmaceuticals announced its subsidiary priced $600 million of senior secured notes due in 2032. They will use the proceeds to refinance existing loans and increase a term loan facility to $2.1 billion.

AI Assistant

AMNEAL PHARMACEUTICALS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.